Taurus Asset Management, LLC Bristol Myers Squibb CO Transaction History

Taurus Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $199,225 - $233,366	-3,367 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $30,831 - $33,575	-498 Reduced 12.88%	3,367 $225,000
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $26,821 - $30,166	-452 Reduced 10.47%	3,865 $244,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $41,923 - $46,457	-730 Reduced 14.46%	4,317 $260,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $54 - $64	-1 Reduced 0.02%	5,047 $297,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $39,368 - $51,352	-800 Reduced 13.68%	5,048 $324,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $9,024 - $10,760	-200 Reduced 3.31%	5,848 $279,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $155,844 - $169,909	2,600 Added 75.41%	6,048 $371,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $190,433 - $219,775	3,448	3,448 $220,000

2,400

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Taurus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Taurus Asset Management, LLC with notifications on news.